DHODH and multiple sclerosis: Because DHODH is required to ensure proliferating-cell viability [2], inhibitors have been developed to eliminate human DHODH (hDHODH) activity, which is associated with cancers, multiple sclerosis, and autoimmune and inflammatory diseases (see below) [3].